ARCHIVES

FDA Likely To Change Procedures For Patient Interaction, Official Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

AACR Receives Record Number of Abstracts

January 27, 1989

Radiology Advocated As First Diagnostic Test After Hemoccult

April 25, 1986

About Face; NCI To Keep Preclinical AIDS Drug Development

December 12, 1986

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

In Their Own Words: “Blessed with The Opportunity” vs. “LOWEST Morale Ever”

May 23, 2014

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011